These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12637204)

  • 1. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness.
    Hayley S; Merali Z; Anisman H
    Stress; 2003 Mar; 6(1):19-32. PubMed ID: 12637204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.
    Anisman H; Merali Z; Hayley S
    Prog Neurobiol; 2008 May; 85(1):1-74. PubMed ID: 18346832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines as a stressor: implications for depressive illness.
    Anisman H; Hayley S; Turrin N; Merali Z
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):357-73. PubMed ID: 12466035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.
    Hayley S; Poulter MO; Merali Z; Anisman H
    Neuroscience; 2005; 135(3):659-78. PubMed ID: 16154288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice.
    Gibb J; Hayley S; Gandhi R; Poulter MO; Anisman H
    Brain Behav Immun; 2008 May; 22(4):573-89. PubMed ID: 18191534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis.
    Simmons DA; Broderick PA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):793-807. PubMed ID: 15923072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia.
    Grippo AJ; Francis J; Beltz TG; Felder RB; Johnson AK
    Physiol Behav; 2005 Apr; 84(5):697-706. PubMed ID: 15885245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress, immunity, cytokines and depression.
    Anisman H
    Acta Neuropsychiatr; 2002 Dec; 14(6):251-61. PubMed ID: 26984573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines as mediators of neuroimmune interactions].
    Miul'berg AA; Grishina TV
    Usp Fiziol Nauk; 2006; 37(1):18-27. PubMed ID: 16522001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
    Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice.
    Hebb AL; Drolet G; Mendella PD; Roach SP; Gauthier MS; Zacharko RM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):453-69. PubMed ID: 16290012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses.
    Johnson JD; O'Connor KA; Watkins LR; Maier SF
    Neuroscience; 2004; 127(3):569-77. PubMed ID: 15283957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors.
    Gandhi R; Hayley S; Gibb J; Merali Z; Anisman H
    Brain Behav Immun; 2007 May; 21(4):477-89. PubMed ID: 17267173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anhedonic and anxiogenic effects of cytokine exposure.
    Anisman H; Merali Z
    Adv Exp Med Biol; 1999; 461():199-233. PubMed ID: 10442175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines as a precipitant of depressive illness: animal and human studies.
    Anisman H; Merali Z; Poulter MO; Hayley S
    Curr Pharm Des; 2005; 11(8):963-72. PubMed ID: 15777247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines, stress and depressive illness: brain-immune interactions.
    Anisman H; Merali Z
    Ann Med; 2003; 35(1):2-11. PubMed ID: 12693607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases.
    Szczepanska-Sadowska E; Cudnoch-Jedrzejewska A; Ufnal M; Zera T
    J Physiol Pharmacol; 2010 Oct; 61(5):509-21. PubMed ID: 21081794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute and sensitization effects of tumor necrosis factor-α: implications for immunotherapy as well as psychiatric and neurological conditions.
    Hayley S; Merali Z; Anisman H
    Acta Neuropsychiatr; 2002 Dec; 14(6):322-35. PubMed ID: 26984578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.